Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

04/08/2020 07:00

Aug 4 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.13                2.74             10.10    
                 (-22.2 pct)         (+1.5 pct)       (-7.5 pct)  
  Operating     loss 213 mln        loss 251 mln        10 mln    
  Recurring     loss 179 mln        loss 232 mln        40 mln    
  Net              33 mln           loss 289 mln        240 mln   
  EPS             0.97 yen          loss 8.35 yen      6.91 yen   
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T